Abliva Competitors and Similar CompaniesClear all
Abliva's competitors and similar companies include WuXi AppTec.
 Abliva Abliva is a biotech company that discovers and develops medicines for the treatment of mitochondrial disease. |  WuXi AppTec WuXi AppTec (无锡药明康德新药开发股份有限公司, formerly known as WuXi PharmaTech) is a company that provides integrated research, development, and manufacturing solutions for drug discovery and production. | |
Founding Date | Founding Date 2000 | Founding Date 2000 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Lund, SE HQ | Locations Shanghai, CN HQ Beijing, CN Changzhou, CN Chengdu, CN Nanjing, CN Nantong, CN Shanghai, CN see more |
Employees | Employees 950% increase | Employees 39,414 |
Financial | ||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥43.1b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ¥23.8b (FY, 2025) |
Gross profit | Gross profit kr497k (FY, 2024) | Gross profit ¥21.3b (FY, 2025) |
Net income | Net income (kr90m) (FY, 2024) | Net income ¥19.3b (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 10.8m | Total funding raised $ 902.6m |
For sources of this data, please see the company profile
View Company Profiles
WuXi AppTec
HQ
Shanghai, CN
Employees
39,414
WuXi AppTec (无锡药明康德新药开发股份有限公司, formerly known as WuXi PharmaTech) is a company that provides integrated research, development, and manufacturing solutions for drug discovery and production.
View company